Corvus Pharmaceuticals (CRVS) Depreciation and Depletion (2015 - 2017)

Corvus Pharmaceuticals' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $211000.0 for Q3 2017.

• In Q3 2017, Depreciation and Depletion rose 32.7% year-over-year to $211000.0; the TTM figure through Sep 2017 stood at $808000.0 (up 73.39% YoY), while the FY2016 annual figure was $594000.0, up 301.35% from the prior year.
• Depreciation and Depletion was $211000.0 for Q3 2017 at Corvus Pharmaceuticals, up from $208000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $211000.0 in Q3 2017 to a low of $1000.0 in Q1 2015.
• Historically, Depreciation and Depletion has averaged $124090.9 across 3 years, with a median of $144000.0 in 2016.
• The sharpest annual moves came in 2016 and 2017: Depreciation and Depletion surged 10500.0% in 2016, then jumped 32.7% in 2017.
• A 3-year view of Depreciation and Depletion shows it stood at $57000.0 in 2015, then soared by 224.56% to $185000.0 in 2016, then gained by 14.05% to $211000.0 in 2017.
• The last three Depreciation and Depletion figures came in at $211000.0 (Q3 2017), $208000.0 (Q2 2017), and $204000.0 (Q1 2017), per Business Quant data.